The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis
C Liang, X Li, L Zhang, D Cui, X Quan… - … and Molecular Pathology, 2015 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial fibrotic lung disease with an
undefined etiology and no effective treatments. By binding to cell surface receptors …
undefined etiology and no effective treatments. By binding to cell surface receptors …
The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis.
C Liang, X Li, L Zhang, D Cui, X Quan… - Experimental and …, 2015 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial fibrotic lung disease with an
undefined etiology and no effective treatments. By binding to cell surface receptors …
undefined etiology and no effective treatments. By binding to cell surface receptors …
The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis
C Liang, X Li, L Zhang, D Cui… - Experimental and …, 2015 - pubmed.ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial fibrotic lung disease with an
undefined etiology and no effective treatments. By binding to cell surface receptors …
undefined etiology and no effective treatments. By binding to cell surface receptors …
The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis
C Liang, X Li, L Zhang, D Cui, X Quan… - … and Molecular Pathology, 2015 - infona.pl
Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial fibrotic lung disease with an
undefined etiology and no effective treatments. By binding to cell surface receptors …
undefined etiology and no effective treatments. By binding to cell surface receptors …